These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4598678)

  • 1. Clinical trial of rapidly dissolving theophylline tablets.
    Hartnett BJ; Marlin GE; Graham G
    Med J Aust; 1974 Apr; 1(14):532-5. PubMed ID: 4598678
    [No Abstract]   [Full Text] [Related]  

  • 2. Theophylline and diaphragmatic contractility. Investigation of a dose-response relationship.
    Foxworth JW; Reisz GR; Knudson SM; Cuddy PG; Pyszczynski DR; Emory CE
    Am Rev Respir Dis; 1988 Dec; 138(6):1532-4. PubMed ID: 3059899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
    Giosue S; Bernocchi D; Parola D; Munno R; Mancini P
    J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability and efficacy of a sustained-release theophylline tablet.
    Mitenko PA; Ogilvie RI
    Clin Pharmacol Ther; 1974 Oct; 16(4):720-6. PubMed ID: 4609343
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind comparison of a microcrystalline theophylline tablet and salbutamol in reversible airways obstruction.
    Tedders JG; Thomas AK; Edwards G
    Br J Clin Pract; 1976; 30(11-12):212-6. PubMed ID: 795447
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1982 Apr; 13(4):569-71. PubMed ID: 7066172
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease.
    Bleecker ER; Britt EJ
    Am J Med; 1991 Oct; 91(4A):24S-27S. PubMed ID: 1835291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism of metaproterenol and theophylline.
    Ziment I; Steen SN
    Chest; 1978 Jun; 73(6 Suppl):1016-7. PubMed ID: 354884
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled evaluation of oral theophylline in asthmatic children.
    Taylor WF; Siegel SC; Busser RJ; Strick L; Heimlich EM
    Ann Allergy; 1968 Oct; 26(10):523-30. PubMed ID: 4877953
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative trial of ipratropium bromide (Atrovent), controlled release theophylline (Phyllocontin), and a combination of these in patients with reversible airflow obstruction.
    Sahay JN; Chatterjee SS; Summerfield PJ
    Br J Clin Pract; 1986 May; 40(5):198-202. PubMed ID: 2944533
    [No Abstract]   [Full Text] [Related]  

  • 16. Unequal twice-daily, sustained-release theophylline dosing in chronic obstructive pulmonary disease.
    Bruguerolle B; Philip-Joet F; Parrel M; Arnaud A
    Chronobiol Int; 1987; 4(3):381-5. PubMed ID: 3315267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessing the therapeutic range for theophylline on laboratory report forms: another viewpoint.
    Jenne JW
    Pharmacotherapy; 1993; 13(6):595-7. PubMed ID: 8302683
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum theophylline levels in chronic obstructive pulmonary disease patients receiving uniphyllin].
    Chang SC; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Jan; 41(1):37-42. PubMed ID: 3167647
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of the serum level of theophylline in a group of patients with chronic obstructive bronchopneumopathy].
    Marzo C; Gnasso P; Dericoloso A; Borrelli G; Vacca C; Cantone F
    Arch Monaldi; 1981; 36(1-2):71-5. PubMed ID: 7348162
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.